| 1 |
35565309 | Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients. | 2022 Apr 27 |
1 |
| 2 |
31625520 | Effects of silver nanoparticles coated with anti-HER2 on irradiation efficiency of SKBR3 breast cancer cells. | 2019 Oct |
2 |
| 3 |
29278813 | A sandwich-type electrochemical immunosensor based on in situ silver deposition for determination of serum level of HER2 in breast cancer patients. | 2018 Apr 30 |
1 |
| 4 |
27579854 | Human epidermal growth factor receptor 2 (HER-2) status evaluation in advanced gastric cancer using immunohistochemistry versus silver in situ hybridization. | 2017 May 20 |
1 |
| 5 |
28413656 | Effect of Ki-67 assessment in the distribution of breast cancer subtypes: Evaluation in a cohort of Latin American patients. | 2017 Apr |
1 |
| 6 |
28554745 | Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine. | 2017 Jul |
1 |
| 7 |
26062614 | The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study. | 2015 Jun 11 |
1 |
| 8 |
23702645 | HER2 gene amplification and protein expression in pancreatic ductal adenocarcinomas. | 2014 |
1 |
| 9 |
24614702 | High concordance rate of HER2 status assessed via silver in situ hybridisation (SISH) between core biopsy and excision specimens: a 4 year retrospective review from a single institution. | 2014 Apr |
1 |
| 10 |
24614718 | HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2: CEP17 ratio? | 2014 Apr |
1 |
| 11 |
24713241 | [Dual-color silver-enhanced in-situ hybridization for determination of HER2 gene amplification in gastric carcinoma]. | 2014 Jan |
2 |
| 12 |
24879338 | HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression. | 2014 |
1 |
| 13 |
24992176 | Delay to formalin fixation effect on HER2 test in breast cancer by dual-color silver-enhanced in situ hybridization (Dual-ISH). | 2014 Oct |
1 |
| 14 |
25153153 | Concomitant detection of HER2 protein and gene alterations by immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) identifies HER2 positive breast cancer with and without gene amplification. | 2014 |
1 |
| 15 |
23238628 | Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas. | 2013 May |
1 |
| 16 |
23282976 | Frequency of HER-2 positivity in rectal cancer and prognosis. | 2013 Apr |
1 |
| 17 |
23334118 | The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study. | 2013 May |
1 |
| 18 |
22124755 | Distinguishing breast cancer cells using surface-enhanced Raman scattering. | 2012 Jan |
2 |
| 19 |
22493625 | Multiplication of Chromosome 17 Centromere Is Associated with Prognosis in Patients with Invasive Breast Cancers Exhibiting Normal HER2 and TOP2A Status. | 2012 Mar |
1 |
| 20 |
21267790 | Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival. | 2011 Jul |
1 |
| 21 |
21307144 | HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care. | 2011 Apr 1 |
1 |
| 22 |
21317877 | Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer. | 2011 Jun |
1 |
| 23 |
21338271 | HER2 status in operable breast cancers from Vietnamese women: Analysis by immunohistochemistry (IHC) and automated silver enhanced in situ hybridization (SISH). | 2011 Apr |
1 |
| 24 |
22323913 | Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer. | 2011 Dec |
1 |
| 25 |
20530441 | Detection of HER2 amplification using the SISH technique in breast, colon, prostate, lung and ovarian carcinoma. | 2010 Apr |
1 |
| 26 |
20802349 | Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients. | 2010 Oct |
1 |
| 27 |
20976182 | Determination of HER-2 status on FNAC material from breast carcinomas using in situ hybridization with dual chromogen visualization with silver enhancement (dual SISH). | 2010 Oct 11 |
1 |
| 28 |
20979875 | [Automated silver-enhanced in situ hybridization detection assay for human epidermal growth factor receptor 2 gene status determination in breast cancer]. | 2010 Jun 22 |
1 |
| 29 |
19762531 | Emerging technologies for assessing HER2 amplification. | 2009 Oct |
1 |
| 30 |
18832456 | Delineation of HER2 gene status in breast carcinoma by silver in situ hybridization is reproducible among laboratories and pathologists. | 2008 Nov |
1 |